Mindset Pharma Strengthens IP Portfolio with Another New Provisional Patent Application Covering its Next-Generation DMT… Apr 19, 2022
Cybin Announces Positive CYB004 Data Demonstrating Significant Advantages Over Intravenous and Inhaled DMT Apr 13, 2022
World’s First clinical trial for DMT-assisted therapy in Major Depressive Disorder Shows Consistent Quality of… Feb 22, 2022
